Dr. Gerald Lipshutz has been awarded the Quest Award by the California Institute for Regenerative Medicine (CIRM)! The $2.3 million award will fund the lab’s work to develop a one-time gene therapy to treat creatine transporter deficiency, which inhibits creatine—a molecule that is an essential energy source for brain and muscle cells—from reaching the brain and muscles and causes neural…... Read More
“Mouse Study Shows Gene Therapy May Correct Creatine Deficiency Disorder” Link: https://www.uclahealth.org/news/LipshutzGAMT2022... Read More
Andrea, Lizzie, and Colleen attended the 25th Annual American Society of Gene and Cell Therapy (ASGCT) Conference. Lizzie and Colleen presented their research.... Read More
Congratulations to Matt on receiving his PhD and starting a new position at Poseida Therapeutics joining Brian Truong!... Read More
We are all very excited to have her join our research group!... Read More
Matt Nitzahn presented his dissertation project to his committee, family and others interested in his work.... Read More
Congratulations to Colleen on her acceptance into the i2URP Program!... Read More
Matt, Suhail, and Jenna attended and presented their research at the 23rd Annual American Society of Gene and Cell Therapy (ASGCT) virtual Conference.... Read More
Congratulations to Brian on receiving his PhD and starting a new job at Poseida Therapeutics!... Read More
Gerry Lipshutz is appointed as a member of the Gene and Drug Delivery Systems (GDD) Study Section for the NIH.... Read More